Wall Street brokerages expect Cigna Corp (NYSE:CI) to announce earnings per share (EPS) of $4.28 for the current quarter, Zacks reports. Five analysts have issued estimates for Cigna’s earnings, with the lowest EPS estimate coming in at $4.17 and the highest estimate coming in at $4.72. Cigna reported earnings of $2.46 per share during the same quarter last year, which indicates a positive year over year growth rate of 74%. The firm is scheduled to report its next earnings report on Friday, February 7th.
According to Zacks, analysts expect that Cigna will report full year earnings of $16.89 per share for the current year, with EPS estimates ranging from $16.60 to $16.99. For the next financial year, analysts forecast that the company will report earnings of $18.61 per share, with EPS estimates ranging from $18.30 to $19.07. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Cigna.
Cigna (NYSE:CI) last issued its earnings results on Thursday, October 31st. The health services provider reported $4.54 EPS for the quarter, topping the consensus estimate of $4.37 by $0.17. The company had revenue of $35.83 billion during the quarter, compared to analyst estimates of $34.20 billion. Cigna had a return on equity of 12.79% and a net margin of 3.30%. The business’s revenue was up 213.1% on a year-over-year basis. During the same quarter last year, the firm earned $3.84 EPS.
In related news, CEO David Cordani purchased 32,509 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The shares were acquired at an average price of $155.17 per share, with a total value of $5,044,421.53. Company insiders own 0.80% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in CI. Redhawk Wealth Advisors Inc. acquired a new position in shares of Cigna during the 2nd quarter valued at $28,000. Virtus ETF Advisers LLC acquired a new position in shares of Cigna during the 2nd quarter valued at $30,000. Garrett Wealth Advisory Group LLC acquired a new position in shares of Cigna during the 3rd quarter valued at $30,000. Knuff & Co LLC acquired a new position in shares of Cigna during the 3rd quarter valued at $30,000. Finally, Optimum Investment Advisors increased its position in shares of Cigna by 258.6% during the 3rd quarter. Optimum Investment Advisors now owns 208 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 150 shares during the period. 87.79% of the stock is currently owned by institutional investors and hedge funds.
Shares of CI traded up $1.81 during mid-day trading on Tuesday, hitting $188.97. The stock had a trading volume of 510,001 shares, compared to its average volume of 2,129,504. The company has a market cap of $70.28 billion, a PE ratio of 13.29, a PEG ratio of 0.95 and a beta of 0.72. The company’s fifty day simple moving average is $164.43 and its two-hundred day simple moving average is $161.21. The company has a quick ratio of 0.63, a current ratio of 0.63 and a debt-to-equity ratio of 0.76. Cigna has a fifty-two week low of $141.95 and a fifty-two week high of $226.60.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Further Reading: Hold Rating
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.